Gastrointestinal stromal tumors (GISTs): Definition, clinical, histological, immunohistochemical, and molecular genetic features, and predictors of malignant potential and differential diagnosis

Archive of Oncology

Volumn 10, Issue 4, 2002, Pages 267-271

  Žvković, Vesna ^a   Katić, Vuka ^a   Nagorni, Aleksandar ^a   Velićković, Ljubinka ^a   Milentijević, Maja ^a   Dordević, Biljana ^a  

^a Faculty of Medicine   (Serbia)

Author keywords

Gastrointestinal neoplasms; Immunohistochemistry; Proto oncogene protein c kit

Indexed keywords

PROTEIN TYROSINE KINASE; STEM CELL FACTOR RECEPTOR;

ARTICLE; CANCER INFILTRATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG TARGETING; GASTROINTESTINAL TUMOR; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MITOSIS RATE; MOLECULAR GENETICS; NOMENCLATURE; PROGNOSIS; TUMOR DIFFERENTIATION; TUMOR NECROSIS;

EID: 0036975410     PISSN: 03547310     EISSN: None     Source Type: Journal    
DOI: 10.2298/AOO0204267Z     Document Type: Article

References (31)

1. Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (kit). Mod Pathol 2000; 13: 1134-42.
2. Appelman HD. Mesenchymal tumors of the gut: historical perspectives, new approaches, new results, and does it make any difference? Monogr Pathol 1990. p. 220-46.
3. Kindblom LG, Remoti HE, Aldenborg F, Meis KJ. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumor show phenotypic characteristics of the interstitial cell of Cajal. Am J Pathol 1998; 152: 1259-69.
4. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30: 1213-20.
5. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol 2000; 24 (1): 211-22.
6. Miettinen M, Moniham JM, Sarlomo-Rikala M, Kovatich AJ, Carr NJ et al. Gastrointestinal stromal tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol 1999; 23 (9): 1109-18.
7. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that in more specific than CD34. Mod Pathol 1998; 11 (8): 728-34.
8. Sircar K, Hewlett BR, Huizinga JD, Chomeyko K, Berezin I, Riddell RH. Interstitial cell of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999; 23; 377-89.
9. Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M. Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol 1999; 154 (1): 53-60.
10. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota, J. Gastrointestinal stromal tumor and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol 2000; 24 (10): 1339-52.
11. Myerson RJ, Michalski JM. Gastrointestinal stromal tumors. In: Rustgi AK, ed. Gastrointestinal cancers: biology, diagnosis, and therapy. Philadelphia: Lippincot-Raven, 1995; 575-84.
12. Pidhorecky I, Cheney RT, Kraybill WG, Gibbs JF. Gastrointestinal stromal tumors: Current diagnosis, biologic behavior and managment. Ann Surg Oncol 2000; 7 (9): 705-12.
13. Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol 1999; 23 (1): 82-7.
14. Ming KW. Small intestinal stromal tumors with skenoid fibers. Clinicopathological, immunohistochemical, and ultrastructural investigations. Am J Surg Pathol 1992; 16: 144-55.
15. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishoguro S et al. Gain-of-function mutations of c-kit in human gastrointestinal tumors. Science 1998; 279; 577-80.
16. Seidel T, Edvardsson H. Expression of c-kit provides information about the possible cell of odgin and clinical course of gastrointestinal stromal tumors. Histopathology 1999; 34: 416-24.
17. Sanders KM. A case for interstitial cells of Cajal as pacemaker and mediators of neurotransmission in gastrointestinal tract. Gastroenterology 1996; 111: 492-515.
18. Sakurai S, Fukasawa T, Chong JM, Tanaka A, Fukayama M. Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstital cells of Cajal. Am J Pathol 1999; 154: 23-28.
19. Young HM, Ciampoli D, Southwell BR, Newgreen DF. Origin of interstitial cell of Cajal in the mouse intestine. Dev Biol 1996; 180: 97-107.
20. Besmer P, Murphy E, George PC, Qui F, Bergold PJ, Lederman L et al. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 1986; 320: 415-21.
21. Nishida T, Hirota S, Taniguchi M, Hashimoto K, Isozaki K, Nakamura H et al. Familiar gastrointestinal stromal tumours with germline mutation of kit gene. Nat Geget 1998; 19: 323-24.
22. Maeyama H, Hidaka E, Ota H, Minami S, Kajiyama M, Kuraishi A et al. Familiar gastrointestinal stromal tumor with hyperpigmentation: association with a germline of the c-kit gene. Gastroenterology 2001; 120: 210-15.
23. Ernst SI, Hubbs AE, Przygodzki RM, Emory TS, Sobin LH, O'Leary TJ. Kit mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab Invest 1998; 78 (12): 1633-6.
24. El-Rifai W, Sarlomo-Rikala M, Miettinen M, Knuuitila S, Andersson LC. DNA copy number losses in chromosome 14: an early changes in gastrointestinal stromal tumors. Cancer Res 1996; 56: 3230-33.
25. Cunningham RE, Federspieh BH, McCarthy WF, Sobin LH, O'Leary TJ. Predicting prognosis of gastrointestinal smooth muscle tumors. Role of clinical and histologic evaluation, flow cytometry, and image cytometry. Am J Surg Pathol 1993; 17: 588-94.
26. Emory TS, Derringer GA, Sobin LH, O'Leary TJ. Ki-61 (MIB-1) immnunohistochemistry as a prognostic factor in gastrointestinal smooth-muscle tumors. J Surg Pathol 1997; 2: 239-42.
27. DeMatteo R, Lewis J, Leung D, Mudan SS, Woodruff J, Brennan M.Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000; 231: 51-8.
28. Clary BM, DeMatteo RP, Lewis JJ, Leung D, Brunnan MF. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: A clinical comparition. Ann Surg Oncol 200; 8 (4): 290-99.
29. Wille P, Borchard F. Fibroid polyp of intestinal tract are inflammatory-reactive proliferations of CD34-positive perivascular cells. Histopathology 1998; 32 (6): 498-502.
30. Coffin CM, Dehner LP, Meis-Kindblom JH. Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations. Semin Diagn Pathol 1998; 15: 102-10.
31. Lauwers GY, Erlandson RA, Casper ES, Brennan MF, Woodruff JM. Gastrointestinal autonomic nerve tumors. A clinicopathological, immunohistochemical, and ultrastructural study of 12 cases. Am J Surg Pathol 1993; 17: 887-97.